{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:18:13Z","timestamp":1760300293682,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s40263-019-00676-6","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T03:58:13Z","timestamp":1571975893000},"page":"1133-1139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis"],"prefix":"10.1007","volume":"33","author":[{"given":"Carolina Gabri","family":"Nicoletti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doriana","family":"Landi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizia","family":"Monteleone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Mataluni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Albanese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetta","family":"Lauretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Simonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Boffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Buttari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola Biagio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8390-8545","authenticated-orcid":false,"given":"Diego","family":"Centonze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girolama Alessandra","family":"Marfia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,24]]},"reference":[{"key":"676_CR1","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","volume":"367","author":"RJ Fox","year":"2012","unstructured":"Fox RJ, Miller DH, Phillips JT, et al. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N Engl J Med. 2012;367:1087\u201397.","journal-title":"N Engl J Med."},{"key":"676_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1055\/s-0033-1343796","volume":"33","author":"J Phillips","year":"2013","unstructured":"Phillips J, Fox R. BG-12 in multiple sclerosis. Semin Neurol. 2013;33:56\u201365.","journal-title":"Semin Neurol."},{"key":"676_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/mc.20465","volume":"48","author":"W Li","year":"2009","unstructured":"Li W, Kong A-N. Molecular mechanisms of Nrf2-mediated antioxidant response. Mol Carcinog. 2009;48:91\u2013104.","journal-title":"Mol Carcinog."},{"key":"676_CR4","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1089\/ars.2012.4671","volume":"19","author":"E Parada","year":"2013","unstructured":"Parada E, Egea J, Buendia I, et al. The microglial \u03b17-acetylcholine nicotinic receptor is a key element in promoting neuroprotection by inducing heme oxygenase-1 via nuclear factor erythroid-2-related factor 2. Antioxid Redox Signal. 2013;19:1135\u201348.","journal-title":"Antioxid Redox Signal."},{"key":"676_CR5","doi-asserted-by":"publisher","first-page":"e1003354","DOI":"10.1371\/journal.pgen.1003354","volume":"9","author":"TA Staab","year":"2013","unstructured":"Staab TA, Griffen TC, Corcoran C, et al. The conserved SKN-1\/Nrf2 stress response pathway regulates synaptic Function in Caenorhabditis elegans. PLoS Genet. 2013;9:e1003354.","journal-title":"PLoS Genet."},{"key":"676_CR6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1871524916666160822115133","volume":"17","author":"M Di Bari","year":"2017","unstructured":"Di Bari M, Di Pinto G, Reale M, et al. Cholinergic system and neuroinflammation: implication in multiple sclerosis. Cent Nerv Syst Agents Med Chem. 2017;17:109\u201315.","journal-title":"Cent Nerv Syst Agents Med Chem."},{"key":"676_CR7","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.4103\/1673-5374.215244","volume":"12","author":"L Foucault-Fruchard","year":"2017","unstructured":"Foucault-Fruchard L, Antier D. Therapeutic potential of \u03b17 nicotinic receptor agonists to regulate neuroinflammation in neurodegenerative diseases. Neural Regen Res. 2017;12:1418.","journal-title":"Neural Regen Res."},{"key":"676_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s002210000543","volume":"135","author":"V Di Lazzaro","year":"2000","unstructured":"Di Lazzaro V, Oliviero A, Profice P, et al. Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res. 2000;135:455\u201361.","journal-title":"Exp Brain Res."},{"key":"676_CR9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1469-7793.2000.t01-1-00503.x","volume":"523","author":"H Tokimura","year":"2000","unstructured":"Tokimura H, Di Lazzaro V, Tokimura Y, et al. Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol. 2000;523:503\u201313.","journal-title":"J Physiol."},{"key":"676_CR10","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444\u201352.","journal-title":"Neurology."},{"key":"676_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/1352458514538885","volume":"21","author":"S Rossi","year":"2015","unstructured":"Rossi S, Rocchi C, Studer V, et al. The autonomic balance predicts cardiac responses after the first dose of fingolimod. Mult Scler. 2015;21:206\u201316.","journal-title":"Mult Scler."},{"key":"676_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292\u2013302.","journal-title":"Ann Neurol."},{"key":"676_CR13","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.clinph.2009.08.016","volume":"120","author":"S Rossi","year":"2009","unstructured":"Rossi S, Hallett M, Rossini PM, et al. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120:2008\u201339.","journal-title":"Clin Neurophysiol."},{"key":"676_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1113\/jphysiol.2005.092155","volume":"569","author":"V Di Lazzaro","year":"2005","unstructured":"Di Lazzaro V, Pilato F, Dileone M, et al. Dissociated effects of diazepam and lorazepam on short-latency afferent inhibition: dissociated effects of benzodiazepines on SAI. J Physiol. 2005;569:315\u201323.","journal-title":"J Physiol."},{"key":"676_CR15","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1212\/01.wnl.0000204183.26231.23","volume":"66","author":"V Di Lazzaro","year":"2006","unstructured":"Di Lazzaro V, Pilato F, Dileone M, et al. In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias. Neurology. 2006;66:1111\u20133.","journal-title":"Neurology."},{"key":"676_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780198566342.001.0001","volume-title":"Autonomic failure: a textbook of clinical disorders of the autonomic nervous system","author":"CJ Mathias","year":"2013","unstructured":"Mathias CJ. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. 5th ed. Oxford: Oxford University Press; 2013.","edition":"5"},{"key":"676_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.brs.2017.09.009","volume":"11","author":"CV Turco","year":"2018","unstructured":"Turco CV, El-Sayes J, Savoie MJ, et al. Short- and long-latency afferent inhibition; uses, mechanisms and influencing factors. Brain Stimul. 2018;11:59\u201374.","journal-title":"Brain Stimul."},{"key":"676_CR18","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1212\/WNL.59.3.392","volume":"59","author":"V Di Lazzaro","year":"2002","unstructured":"Di Lazzaro V, Oliviero A, Tonali PA, et al. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology. 2002;59:392\u20137.","journal-title":"Neurology."},{"key":"676_CR19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.neuroimage.2007.05.003","volume":"37","author":"V Di Lazzaro","year":"2007","unstructured":"Di Lazzaro V, Pilato F, Dileone M, et al. Functional evaluation of cerebral cortex in dementia with Lewy bodies. Neuroimage. 2007;37:422\u20139.","journal-title":"Neuroimage."},{"key":"676_CR20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00702-011-0725-3","volume":"119","author":"R Nardone","year":"2012","unstructured":"Nardone R, Bergmann J, Christova M, et al. Short latency afferent inhibition differs among the subtypes of mild cognitive impairment. J Neural Transm. 2012;119:463\u201371.","journal-title":"J Neural Transm."},{"key":"676_CR21","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/mds.25040","volume":"27","author":"O Celebi","year":"2012","unstructured":"Celebi O, Temu\u00e7in \u00c7M, Elibol B, et al. Short latency afferent inhibition in Parkinson\u2019s disease patients with dementia. Mov Disord. 2012;27:1052\u20135.","journal-title":"Mov Disord."},{"key":"676_CR22","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.4049\/jimmunol.1501613","volume":"196","author":"W Jiang","year":"2016","unstructured":"Jiang W, St-Pierre S, Roy P, et al. Infiltration of CCR22+ Ly6Chigh proinflammatory monocytes and neutrophils into the central nervous system is modulated by nicotinic acetylcholine receptors in a model of multiple sclerosis. J Immunol. 2016;196:2095\u2013108.","journal-title":"J Immunol."},{"key":"676_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jneuroim.2008.06.018","volume":"203","author":"E Nizri","year":"2008","unstructured":"Nizri E, Irony-Tur-Sinai M, Faranesh N, et al. Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine. J Neuroimmunol. 2008;203:12\u201322.","journal-title":"J Neuroimmunol."},{"key":"676_CR24","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/glia.23101","volume":"65","author":"RD Fields","year":"2017","unstructured":"Fields RD, Dutta DJ, Belgrad J, et al. Cholinergic signaling in myelination: cholinergic signaling in myelination. Glia. 2017;65:687\u201398.","journal-title":"Glia."},{"key":"676_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00401-011-0849-4","volume":"122","author":"E-J Kooi","year":"2011","unstructured":"Kooi E-J, Prins M, Bajic N, et al. Cholinergic imbalance in the multiple sclerosis hippocampus. Acta Neuropathol. 2011;122:313\u201322.","journal-title":"Acta Neuropathol."},{"key":"676_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/ana.410070209","volume":"7","author":"RK Khurana","year":"1980","unstructured":"Khurana RK, Watabiki S, Hebel JR, et al. Cold face test in the assessment of trigeminal-brainstem-vagal function in humans. Ann Neurol. 1980;7:144\u20139.","journal-title":"Ann Neurol."},{"key":"676_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbr.2016.04.012","volume":"308","author":"I Majkutewicz","year":"2016","unstructured":"Majkutewicz I, Kurowska E, Podlacha M, et al. Dimethyl fumarate attenuates intracerebroventricular streptozotocin-induced spatial memory impairment and hippocampal neurodegeneration in rats. Behav Brain Res. 2016;308:24\u201337.","journal-title":"Behav Brain Res."},{"key":"676_CR28","doi-asserted-by":"publisher","first-page":"691","DOI":"10.4049\/jimmunol.1601649","volume":"198","author":"R Li","year":"2017","unstructured":"Li R, Rezk A, Ghadiri M, et al. Dimethyl fumarate treatment mediates an anti-inflammatory shift in B cell subsets of patients with multiple sclerosis. J Immunol. 2017;198:691\u20138.","journal-title":"J Immunol."},{"key":"676_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1742-2094-7-30","volume":"7","author":"H Wilms","year":"2010","unstructured":"Wilms H, Sievers J, Rickert U, et al. Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1\u03b2, TNF-\u03b1 and IL-6 in an in-vitro model of brain inflammation. J Neuroinflamm. 2010;7:30.","journal-title":"J Neuroinflamm."},{"key":"676_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00401-015-1422-3","volume":"130","author":"B Parodi","year":"2015","unstructured":"Parodi B, Rossi S, Morando S, et al. Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS. Acta Neuropathol. 2015;130:279\u201395.","journal-title":"Acta Neuropathol."},{"key":"676_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ceca.2012.12.003","volume":"53","author":"B Brawek","year":"2013","unstructured":"Brawek B, Garaschuk O. Microglial calcium signaling in the adult, aged and diseased brain. Cell Calcium. 2013;53:159\u201369.","journal-title":"Cell Calcium."},{"key":"676_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/B978-0-12-385952-5.00005-1","volume":"62","author":"CC Blad","year":"2011","unstructured":"Blad CC, Ahmed K, IJzerman AP, et al. Biological and pharmacological roles of HCA receptors. Adv Pharmacol. 2011;62:219\u201350.","journal-title":"Adv Pharmacol"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-019-00676-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-019-00676-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-019-00676-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T23:25:04Z","timestamp":1603409104000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-019-00676-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,24]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["676"],"URL":"https:\/\/doi.org\/10.1007\/s40263-019-00676-6","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"type":"print","value":"1172-7047"},{"type":"electronic","value":"1179-1934"}],"subject":[],"published":{"date-parts":[[2019,10,24]]},"assertion":[{"value":"24 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Carolina Gabri Nicoletti, Doriana Landi, Fabrizia Monteleone, Giorgia Mataluni, Maria Albanese, Benedetta Lauretti, Camilla Rocchi, Ilaria Simonelli, Laura Boffa, Fabio Buttari, Nicola Biagio Mercuri, Diego Centonze, and Girolama Alessandra Marfia declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the local Ethics Committee of the University Hospital Tor Vergata, Rome (Italy).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants signed a written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study did not receive any financial support.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}